Dialysis-associated hyperglycemia: manifestations and treatment.
Yijuan SunMaria-Eleni RoumeliotiKavitha GantaRobert H GlewJames GibbDarlene VigilCatherine DoKaren S ServillaBrent WagnerJonathan G OwenMark RohrscheibRichard I DorinGlen H MurataAntonios H TzamaloukasPublished in: International urology and nephrology (2020)
In DAH, insulin infusion is the primary management strategy and corrects the fluid and electrolyte abnormalities. Patients treated for DAH should be monitored for the development of hypoglycemia or fluid and electrolyte abnormalities that may require additional treatments.